Skip to main content

Advancing agile gene editing innovations for the benefit of our communities

Caribou is a leading clinical-stage biotechnology company, founded by pioneers of CRISPR biology, using CRISPR genome editing to discover and develop immune cell-based therapeutics for cancer. Caribou believes that cell therapies are critical now and for the future of cancer therapy and that genome editing is necessary to develop sophisticated cell therapies to treat a variety of different malignancies. The Company is developing a pipeline of genome-edited off-the-shelf CAR-T cell and natural killer (NK) cell therapies for a range of tumor types. Additionally, Caribou offers licenses to its CRISPR-Cas9 foundational IP in multiple fields including research tools, internal research use, diagnostics, and industrial biotechnology.

Our values

  • Leaders in Gene Editing: Passionate and relentless in our pursuit
  • Collaboration: Shaping a better future together
  • Scientific Excellence: Innovating solutions to advance scientific applications
  • Community Engagement: Addressing society's needs through open dialogue
  • Integrity: Operating with the highest level of integrity
  • Personal Development: Empowering and supporting one another
  • Respectful and Inclusive: Everyone is a necessary component of our success

Members of the Caribou herd open their minds to new ideas and welcome diverse perspectives. We proudly assert that teams do their best work when their members are personally engaged, their ideas are taken seriously, their contributions are recognized, and their needs are met.

Our commitment to quality

We are dedicated to developing cutting-edge solutions for cellular engineering and analysis by combining scientific expertise and integrity with quality systems, to deliver beneficial and safe products that meet or exceed customer expectations. On a personal and professional level, we are committed to protecting the health and safety of our employees, customers, and natural environment. All of our business is conducted in accordance with the highest ethical standards and in compliance with all applicable laws.

Learn more and reach out

You can learn more about our technologies and therapeutic pipeline by checking out the Technology and Pipeline pages. If you have a promising application for one of our genome editing technologies or would like to work with us to develop a new one, please contact us.


The Caribou CRISPR technology platform enables high fidelity, multiplex engineering of a wide variety of cells and organisms. Learn more.


Caribou is advancing multiple gene-edited, off-the-shelf cell therapies for cancer. Learn more.


Connect with us on Twitter for the latest news and updates. Click here.

Contact Us

For media and investor inquiries and general information, click here.